Cat. No.: X23-12-YM059

LXS196

Synonym: 1874276-76-2; Darovasertib

  • CAS Number: 1874276-76-2
  • PubChem CID: 118873253
Product Size
2 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
LXS196, soluble in DMSO and ethanol and insoluble in water, blocks the function of Smad proteins in the TGF-β signaling pathway. It targets GSK3β, PKCα, and PKCθ.
Molecular Weight
472.47
Molecular Formula
C22H23F3N8O
Targets
GSK3β: 3.1 μM; PKCα: 1.9 nM; PKCθ: 0.4 nM
Form
Lyophilized powder
Purity
>98%
Solubility
DMSO: 20 mg/mL (42.33 mM); Water: insoluble; Ethanol: 5 mg/mL (10.58 mM)
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
LXS196 can be used as a novel approach for managing various types of pain, including neuropathic pain and inflammatory pain.
Storage
Store at -20℃, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.